Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cellect One Shield HOCL
- Development stage
- Unknown
- Lead developer
- Globe Net Wireless
- Modality
- Drug Delivery Systems, Small Molecules
- Administration
- Topical
01
Overview
Cellect One Shield HOCL is a topical skincare solution containing less than 1% hypochlorous acid (HOCL), a molecule naturally produced by the human immune system. It is designed for gentle cleansing, supporting natural healing, and aiding in skin repair without harsh chemicals or irritation. The product is alcohol-free and free of artificial colors or fragrances, making it suitable for all skin types including sensitive and acne-prone skin. Its mechanism leverages the antimicrobial and anti-inflammatory properties of hypochlorous acid to neutralize pathogens while soothing inflammation. This makes it beneficial for wound care, post-procedure recovery, eczema, rosacea, acne-prone skin, and general maintenance of healthy skin[1][2].
- Brand names
- Cellect One Shield HOCLCellect One Shield
- Other names
- Cellect One Shield Hypochlorous AcidSHIELD HOCL
Beyond the preview
Go deeper on Cellect One Shield HOCL.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cellect One Shield HOCL.